Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

By A. Menter, S. Tyring, K. Gordon, A. Kimball, C. Leonardi, R. Langley, B. Strober, M. Kaul, Yihua Gu, M. Okun and 1 more. Journal of American Academy of Dermatology, 2008

894 citations recorded by the source corpus.

Subfields: Dermatology, Immunology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/6c982c48aa02a6e80649314af69ac4a17f797b10